Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Action of intravenously administered talipexole on the rat striatal neurons receiving excitatory input from nigral dopamine neurons

  • 19 Accesses

  • 12 Citations

Abstract

Electrophysiological studies using rats anesthetized with chloral hydrate were performed to elucidate whether or not intravenously injected talipexole acted as a D2 receptor agonist on the striatal neurons in comparison with the action of bromocriptine. The activities of the striatal neurons were extracellularly recorded using a glass microelectrode attached along a seven-barreled micropipette, each barrel of which was filled with talipexole, bromocriptine, SCH23390 (D1 antagonist), domperidone (D2 antagonist), glutamate or 2 M NaCl. These drugs were iontophoretically applied to the immediate vicinity of the target neuron being recorded. The effects of talipexole and bromocriptine were examined on the neurons, whose spikes (induced by the stimulation of the substantia nigra pars compacta) were inhibited by the iontophoretic application of domperidone. Iontophoretic application of talipexole or bromocriptine increased spontaneous firing of these neurons and this increase in firing was also inhibited by iontophoretically applied domperidone. In the same neurons, intravenously administered talipexole (0.01, 0.02 and 0.04 mg/kg) dose-dependently increased firing, and this increase was inhibited by microiontophoretically applied domperidone, but not by SCH23390. On the other hand, the intravenous injection of bromocriptine (0.1, 0.2 and 0.4 mg/kg) also increased the firing rate. However, the increase was not dose-dependent and fluctuated; the firing transiently decreased during the increase in firing with intravenously administered bromocriptine. However, the bromocriptine-induced increase in firing was also suppressed by domperidone, and decrease in firing was inhibited by SCH23390. These findings suggest that talipexole acts as a D2 agonist on the striatal neurons receiving input from substantia nigra pars compacta and increases firing when intravenously applied. However, intravenously administered bromocriptine appears to act as both a D2 agonist and probably as a D1 agonist on the striatal neurons to increase and decrease firing, respectively.

This is a preview of subscription content, log in to check access.

References

  1. Akaike A, Ohno Y, Sasa M, Takaori S (1987) Excitatory and inhibitory effects of dopamine on neuronal activity of the caudate nucleus neurons in vitro. Brain Res 418:262–272

  2. Bernardi G, Marciani MG, Morocutti C, Pavone F, Stanzione P (1978) The action of dopamine on rat caudate neurones intracellularly recorded. Neurosci Lett 8:235–240

  3. Clarke PBS, Wyder KJ, Jakubovic A, Fibiger HC (1990) Effects of B-HT 920 on nigrostriatal and mesolimbic dopamine systems in normosensitive and supersensitive rats. Br J Pharmacol 99:509–515

  4. Fujimoto S, Sasa M, Takaori S (1981) Inhibition from locus coeruleus of caudate neurons activated by nigral stimulation. Brain Res Bull 6:267–274

  5. Herrling PL, Hull CD (1980) Iontophoretically applied dopamine depolarizes and hyperpolarizes the membrane of cat caudate neurons. Brain Res 192:441–462

  6. Hinzen D, Hornykiewicz O, Kobinger W, Pichler L, Pifl C, Schingnitz G (1986) The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson's disease: a novel approach to treatment. Eur J Pharmacol 131:75–86

  7. Johansen PA, Clarkl D, White FJ (1988) B-HT 920 stimulates post-synaptic D2 dopamine receptors in the normal rat: electrophysiological and behavioral evidence. Life Sci 43:515–524

  8. Kita T, Kita H, Kitai ST (1984) Passive electrical membrane properties of rat neostriatal neurons in an in vitro slice preparation. Brain Res 300:129–139

  9. Kitai ST, Sugimori M, Kocisis JD (1976) Excitatory nature of dopamine in the nigro-caudate pathway. Exp Brain Res 24:351–363

  10. Momiyama T, Sasa M, Takaori S (1991) Inhibition by talipexole, a thiazoloazepine derivative, of dopaminergic neurons in the ventral tegmental area. Life Sci 49:535–543

  11. Ohno Y, Sasa M, Takaori S (1985) Dopamine D-2 receptor-mediated excitation of caudate nucleus neurons from the substantia nigra. Life Sci 37:1515–1521

  12. Ohno Y, Sasa M, Takaori S (1986) Excitation by dopamine D-2 receptor agonists, bromocriptine and LY 171555, in caudate neurons activated by nigral stimulation. Life Sci 38:1867–1873

  13. Ohno Y, Sasa M, Takaori S (1987) Coexistence of inhibitory dopamine D-1 and excitatory D-2 receptors on the same caudate nucleus neurons. Life Sci 40:1937–1945

  14. Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Academic Press, Australia North Ryde

  15. Pettibone DJ, Totaro JA, Clineschmidt BV (1987) Binding of (+)PHNO and other D2-dopamine agonists to D1-dopamine receptors labelled by [3H] SCH23390. J Neural Transm 69:147–151

  16. Schrell UMH, Fahlbusch R, Adams EF, Nomikos P, Reif M (1990) Growth of cultured human cerebral meningiomas is inhibited by dopaminergic agents: presence of high affinity dopamine-D1 receptors. J Clin Endocrinol Metab 71:1669–1671

  17. Todo N, Momiyama T, Amano T, Kohno Y, Sasa M (1994) Excitation by talipexole, a dopamine D2 agonist, of caudate nucleus neurons activated by nigral stimulation. Life Sci 54:957–966

  18. Yamada K, Nagashima M, Kimura H, Matsumoto S, Furukawa T (1989) Possible involvement of differing classes of dopamine D-2 receptors in yawning and stereotypy in rats. Psychopharmacology 100:141–144

  19. Yamada K, Matsumoto S, Nagashima M, Shirakawa K, Furukawa T (1990) Potentiation of yawning responses to the dopamine receptor agonists B-HT 920 and SND 919 by pindolol in the rat. J Neural Transm 79:19–24

Download references

Author information

Correspondence to M. Sasa.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Matsubayashi, H., Amano, T., Hongjing, Y. et al. Action of intravenously administered talipexole on the rat striatal neurons receiving excitatory input from nigral dopamine neurons. Psychopharmacology 120, 369–375 (1995). https://doi.org/10.1007/BF02245807

Download citation

Key words

  • Dopamine D2 agonists
  • Talipexole
  • Bromocriptine
  • Intravenous injection
  • Microiontophoresis
  • Electrophysiology and striatal neuron